Trending...
- Massachusetts: Baker-Polito Administration Launches COVID-19 Vaccine CDC Pharmacy Partnership - Phase 1, Expands Vaccine Locations & Names Fenway Park as Mass Vaccination Site
- Boston: A message from Commissioner McCosh: Inauguration event accessibility
- The Atlas Group adds Corbin Raines to their list of professional property managers
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at the 39th Annual J.P. Morgan Virtual Healthcare Conference on January 12, 2021 at 9:10 a.m. (Eastern Time)
To listen to the live audio webcast of the presentation, please visit http://investors.insulet.com. A replay of the audio webcast will also be available following the event.
More on Boston Chron
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit: www.insulet.com and www.myomnipod.com.
To listen to the live audio webcast of the presentation, please visit http://investors.insulet.com. A replay of the audio webcast will also be available following the event.
More on Boston Chron
- Congressional Medal of Honor Society will host 2021 convention in Boston
- Boston: Update on the Ronan Park Well
- Avery Design Announces CXL™ 2.0 VIP
- Nova Biomedical FLEX2 Cell Culture Analyzer Adds Sample Retain Capability
- Kaizen Finance Launches Staking to Foster the Widespread Adoption of DeFi
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit: www.insulet.com and www.myomnipod.com.
Filed Under: Business
0 Comments
Latest on Boston Chron
- Haemonetics Welcomes New FDA Guidance on Viscoelastic Testing During COVID-19 Pandemic
- Massachusetts: Baker- Polito Administration Expands Vaccine Access to All Eligible Residents in Phase One Effective Immediately
- China Refuses to Accept Service of Berman Law Group's Coronavirus Class Action Complaint
- Love & Sip Valentine Brunch with Celebrity The Comedian, Tomea, Grammy Saxophonist Jason Davis, Gospel Contemporary Duo, Only God Ministries
- Massachusetts: Baker-Polito Administration Awards Another $37 Million in Grants to 638 Businesses, Extends Capacity Limits and Lifts Early Closing Requirement for Businesses
- Phio Pharmaceuticals Announces $14.0 Million Private Placement Priced At-the-Market
- Wanderful Partners with Intrepid Travel to Launch Women and Allies Cruise in Antarctica
- Rustic Deco Launches B2B Wholesale Furniture Website
- Jenzabar Makes Senior Management Additions to its Business Development and Customer Operations Teams
- Hybrid Electric Vehicles: A Stay of Execution for NiMH Batteries, Explores IDTechEx
- Technological Innovation Required to Fill Gap in Indoor Navigation for Blind, Finds Strategy Analytics
- Massachusetts: Governor Baker Appoints Jamey Tesler Acting DOT Secretary Following MassDOT Secretary Stephanie Pollack's Appointment to the Federal Highway Administration
- IOTech names Gavin Hunter as VP of global marketing
- FundCount Named Best Hedge Fund System in the Bobsguide Awards
- Introducing BIAMI.IO Apps Framework
- Pro Golfer Kamaiu Johnson Joins Cambridge Mobile Telematics as Brand Ambassador
- Empirix Helps CEHE Confidently Migrate to Five9 Cloud-Based Contact Center Software USA - English USA - English
- Northway Biotech Opens New Biopharmaceutical Manufacturing Facility in Greater Boston Area
- Manulife Investment Management announces new managing director of institutional distribution, southeast region
- Boston: Meet some of this year's Opportunity Fund grantees